Calm Expands Into Clinical Healthcare

Diving deeper into

Calm

Company Report
Their acquisition of Ripple Health Group (02/2022) marks their expansion into clinical healthcare.
Analyzed 6 sources

The Ripple deal turned Calm from a consumer subscription app into a company that could sell into the healthcare system. Ripple brought healthcare navigation software and leadership from Rally Health, which gave Calm the pieces to build Calm Health, a product sold through insurers, health systems, and employers instead of only through app store subscriptions. That matters because clinical distribution is larger, stickier, and tied to care workflows rather than consumer habit alone.

  • Before the acquisition, Calm was already adjacent to care through Kaiser Permanente, which offered Calm to members and had used it in clinical settings. Ripple moved Calm one step deeper, from a wellness benefit around care to software that could sit inside care pathways.
  • After the deal, Calm used the Ripple team to launch Calm Health in October 2022. The product was built for payers, providers, and self insured employers, and focused on screening, care navigation, and condition specific mental health support, not just meditation and sleep content.
  • The business model also changes. Consumer Calm makes money one subscriber at a time. Calm Health can be sold in larger contracts to plans and employers, which is important for a company whose estimated ARR rose to $450M in 2021 and then fell to about $300M in 2022 and 2023.

This points toward Calm becoming mental health infrastructure for benefits and care delivery. The likely next step is deeper insurer and provider distribution, where Calm is embedded as a front door for screening, triage, and ongoing support, with the consumer app acting as the engagement layer that keeps patients coming back between visits.